The trade in counterfeit medicines is flourishing. This Spotlight looks at how can new technologies help to detect fakes; what will it take for developing countries to thwart the trade; and whether current policies targeting the right threat to patients' health.
(Photo credit: WHO/P. Virot)
Developing countries must be given all the scientific, technical and legal help they need to counter the growing trade in fake medicines.
Both fake and substandard medicines threaten public health, and efforts to tackle them must put the focus on quality, says Leena Menghaney.
Pakistan’s sore need for a drug regulatory body was highlighted by the deaths of 125 heart patients from contaminated medicines.
12 March 2012
Priya Shetty explores the tools and partnerships that help the public health community counter the threat of counterfeit medicines.